◆
Dual-mechanism GH stimulation: sustained baseline release plus precise pulsatile peaks.
FREE SHIPPING ON ORDERS OVER $100
Dose ranges reflect commonly studied amounts in published research models. This is not medical advice. For research use only. Not for human consumption.
Protocol Comparison
Growth Hormone · Recovery · Body Composition
Research dose range
Standard research range
0.2 - 0.5 mg
Most referenced blend range in CJC-1295/Ipamorelin synergistic GH secretion research.
Research focus
GH secretion
Observed window
8-12 weeks
Administration
2-3x daily or before sleep
Primary pathway
GHRH + Ghrelin receptors
CJC-1295 provides sustained GH baseline. Ipamorelin adds selective pulsatile peaks. Studies show 3-5x GH output increase.
PROTOCOL BENEFITS
◆
Dual-mechanism GH stimulation: sustained baseline release plus precise pulsatile peaks.
◆
Ipamorelin stimulates GH without elevating cortisol, prolactin, or appetite.
◆
Broad spectrum benefits across lean muscle, fat metabolism, sleep quality, skin elasticity, and recovery.
SCIENCE
CJC-1295 and Ipamorelin work through distinct but complementary mechanisms.
Together, they recreate the natural rhythm of growth hormone release: sustained baseline plus sharp pulsatile spikes.
WHAT TO EXPECT
Improved sleep quality is often the first observation within 1-2 weeks. Body composition and recovery improvements develop over 8-12 weeks.
PROTOCOL NOTE
5mg CJC-1295 + 5mg Ipamorelin per vial. For research use only. Full usage documentation included with every order.
RELATED PRODUCTS
Regeneration · Skin · Recovery
The most advanced regenerative protocol in one vial.
Healing · Recovery · Anti-Inflammatory
Your body's own protection compound, amplified.
Recovery · Healing · Performance
Two of the most powerful healing peptides. One vial. Zero compromise.